IN FOCUS FEATURE
Biofuels Boosters Celebrate at Center's Grand Opening
FROM OUR WEB SITE
From Our Web Site
Talecris Announces 2008 Grant Program
Talecris Biotherapeutics Inc., headquartered in Research Triangle Park, is accepting applications for its 2008 Talecris New Trials Support program (Talents), a research grant program for studies in intravenous immunoglobulin therapies.
Liquidia Granted License for Protein Process
UNC researchers grant an exclusive license to Liquidia Technologies for a protein particle fabrication process known as PRINT (Particle Replication in Non-Wetting Templates).
Pediatric Brain Tumor Foundation Gives Duke $6 Million
The Pediatric Brain Tumor Foundation (PBTF) is giving $6 million to its research institute at Duke University to further the work started by a $6 million grant it gave in 2003 to create the institute.
Register Now for Biotech 2008
Winston-Salem is the site for this year's annual gathering of the state's bioscience community. Don't miss the networking, speakers and exchange of ideas on Monday and Tuesday.
Biofuels Center Celebrates Grand Opening
The Biofuels Center of North Carolina held its Grand Opening Friday, May 9 at its facility in Oxford. Read more details and see pictures in this week's In Focus
Duke Spinout Argos Advances HIV Therapy Trials
Durham's Argos Therapeutics enters a Phase 2a clinical trial on its RNA-based HIV treatment.
Durham's Aldagen Files IPO to Pursue Clinical Trials
Aldagen will go public if SEC approves IPO registration.
Quintiles Transnational to Buy Eidetics
Quintiles Transnational will add to its fast-growing consulting business after signing an agreement to purchase Boston-based Eidetics.
UNC Picks Thorp to be Chancellor
Holden Thorp, an acclaimed chemistry professor and dean of the college of arts and sciences at the University of North Carolina at Chapel Hill, will be the next UNC chancellor.
BDSI's Pain Patch Does Well in Human Trial
The pain patch on which BioDelivery Sciences International has bet its future came up a winner in its latest round of human testing, the Raleigh drug company announced last week.
In Focus
Biofuels Boosters Celebrate at Center's Grand Opening
The Biofuels Center of North Carolina held its Grand Opening Friday, May 9 at its facility in Oxford. The state-funded, non-profit center plans to develop a statewide alternative-fuels industry in an effort to reduce dependence on imported oil. Nowhere else in the world is there a Biofuels Center of its kind.
The event on Friday served as the official kickoff of the state’s commitment to replace 10 percent of its annual 5.6 billion gallons of imported liquid fuels with home-grown and -processed biofuels.
In this week's In Focus, read Jim Shamp's report on the celebration.
News from Other Sites
Duke Study office opens
David Murdock and representatives from Duke University officially opened the MURDOCK Study’s offices in Cannon Village in Kannapolis.
From Independent Tribune
Opening Nears for Research Campus
The constuction of the North Carolina Research Campus' first buildings is nearing completion.
From WRAL LocalTechWire
Headquarters for MURDOCK Study officially opens
More than 200 people celebrated the Murdock study headquarters May 8 in Cannon Village.
From Salisbury Post
Community Watch
- Salix Pharmaceuticals, Ltd. presented at the Bank of America 2008 Healthcare Conference on Wednesday. Interested parties can access a replay of the presentation here.
- Tranzyme Pharma announced that Dr. Philippa Charlton has joined the Company as medical director, clinical development, a newly created position. In this new position, Dr. Charlton will play a pivotal role in the planning and execution of advanced clinical programs for the company’s lead compounds, TZP-101 and TZP-102.
Please send Community Watch items to Jim Shamp.
Save the Date
June 12
SBIR/STTR Proposal Preparation Workshop
(Research Triangle Park)
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
Dec. 4-5
SE Bio Investor Forum
(Palm Beach, Fla.)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, May 15, 2008. For the latest headlines from North Carolina's biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.